SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1

Qian Wanga Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;b Pandemic Research Alliance unit at the Wu Family Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Yicheng Guoa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Logan T. Schwanzc Department of Pathobiology and Mechanisms of Disease, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Ian A. Mellisa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;d Department of Pathology and Cell Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Yiwei Sune Department of Biomedical Informatics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Yiming Quf Department of Systems Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Guillaume Urtechof Department of Systems Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

Riccardo Valdezg Department of Pathology, University of Michigan, Ann Arbor, MI, USAView further author information

Emily Stonemanh Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USAView further author information

Aubree Gordoni Department of Epidemiology, University of Michigan, Ann Arbor, MI, USAView further author information

Harris H. Wangf Department of Systems Biology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information

David D. Hoa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;b Pandemic Research Alliance unit at the Wu Family Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;j Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;k Department of Microbiology and Immunology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USACorrespondence[email protected]
View further author information

Lihong Liul State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, People’s Republic of China;m Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, People’s Republic of China;a Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA;j Division of Infectious Diseases, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USACorrespondence[email protected]
View further author information

show all

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date